Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family
First Claim
Patent Images
1. A method of upregulating a function of and/or the expression of a Dystrophin family polynucleotide selected from SEQ ID NO 2 or a polyuncleotide encoding such a sequence in patient cells or tissues in vivo or in vitro comprising:
- contacting said cells or tissues with at least one antisense oligonucleotide of about 15-30 nucleotides in length that is complementary to and specifically hybridizable with a 15-30nucleotide region of a natural antisense polynucleotide;
of the UTRN Dystrophin family polynucleotide;
thereby upregulating a function of and/or the expression of the Dystrophin family polynucleotide in patient cells or tissues in vivo or in vitro.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Dystrophin family, in particular, by targeting natural antisense polynucleotides of Dystrophin family. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of DMD family.
202 Citations
11 Claims
-
1. A method of upregulating a function of and/or the expression of a Dystrophin family polynucleotide selected from SEQ ID NO 2 or a polyuncleotide encoding such a sequence in patient cells or tissues in vivo or in vitro comprising:
- contacting said cells or tissues with at least one antisense oligonucleotide of about 15-30 nucleotides in length that is complementary to and specifically hybridizable with a 15-30nucleotide region of a natural antisense polynucleotide;
of the UTRN Dystrophin family polynucleotide;
thereby upregulating a function of and/or the expression of the Dystrophin family polynucleotide in patient cells or tissues in vivo or in vitro. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
- contacting said cells or tissues with at least one antisense oligonucleotide of about 15-30 nucleotides in length that is complementary to and specifically hybridizable with a 15-30nucleotide region of a natural antisense polynucleotide;
Specification